Completion of Conditional Placing and TVR
Eden Research plc has successfully completed its Conditional Placing, raising approximately £10.8 million in total through various offerings. Following the satisfaction of conditions, 190,000,000 New Ordinary Shares will be admitted to AIM on or around April 13, 2026. Post-admission, the company will have 803,362,994 ordinary shares in issue, with each carrying one vote, resulting in a total of 803,362,994 voting rights.
Select text to share a quote on X · sign in to keep highlights & notes in your EDEN notes
Completion of Conditional Placing
Total Voting Rights
The Board of Eden Research plc (the "Company") (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, is pleased to announce the successful completion of its Conditional Placing, as previously announced on 2 February 2026, having now satisfied the relevant conditions set out in the Circular.
Following completion, the Company has, in aggregate, raised approximately £10.8 million, inclusive of the Firm Placing, Firm Subscription, Retail Offer and Conditional Placing.
Admission and Total Voting Rights
Following satisfaction of the conditions, and conditional on Second Admission, a total of 190,000,000 New Ordinary Shares will be admitted to trading on AIM ("Admission") at 8.00 a.m. on or around 13 April 2026.
Following Second Admission, the total number of Ordinary Shares in the capital of the Company in issue will be 803,362,994 with each Ordinary Share carrying the right to one vote. There are no shares held in treasury and therefore, following Admission, the total number of voting rights in the Company will be 803,362,994.
Capitalised terms used in this announcement have the meaning given to them in the announcement dated 2 February 2026 and 5 February 2026, unless otherwise defined in this announcement.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.